Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives.
Schnyder JL, de Jong HK, Bache EB, van Hest RM, Schlagenhauf P, Borrmann S, Hanscheid T, Grobusch MP. Schnyder JL, et al. Among authors: hanscheid t. Travel Med Infect Dis. 2023 Mar-Apr;52:102520. doi: 10.1016/j.tmaid.2022.102520. Epub 2022 Dec 14. Travel Med Infect Dis. 2023. PMID: 36526126 Free article.
Fluid therapy in sepsis? Pathogen-specific perspectives.
Kalkman LC, Hanscheid T, Krishna S, Grobusch MP. Kalkman LC, et al. Among authors: hanscheid t. New Microbes New Infect. 2022 Sep 27;49-50:101035. doi: 10.1016/j.nmni.2022.101035. eCollection 2022 Nov-Dec. New Microbes New Infect. 2022. PMID: 36324876 Free PMC article. No abstract available.
Antimalarial treatment in infants.
Kalkman LC, Hanscheid T, Krishna S, Kremsner PG, Grobusch MP. Kalkman LC, et al. Among authors: hanscheid t. Expert Opin Pharmacother. 2022 Oct;23(15):1711-1726. doi: 10.1080/14656566.2022.2130687. Epub 2022 Oct 5. Expert Opin Pharmacother. 2022. PMID: 36174125 Review.
Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research.
Schnyder JL, de Jong HK, Schlagenhauf P, Borrmann S, Hanscheid T, Grobusch MP. Schnyder JL, et al. Among authors: hanscheid t. Travel Med Infect Dis. 2022 Sep-Oct;49:102365. doi: 10.1016/j.tmaid.2022.102365. Epub 2022 May 31. Travel Med Infect Dis. 2022. PMID: 35661741 Free article. Review.
Fluid therapy for severe malaria.
Kalkman LC, Hänscheid T, Krishna S, Grobusch MP. Kalkman LC, et al. Among authors: hanscheid t. Lancet Infect Dis. 2022 Jun;22(6):e160-e170. doi: 10.1016/S1473-3099(21)00471-0. Epub 2022 Jan 17. Lancet Infect Dis. 2022. PMID: 35051406 Review.
101 results